News
6h
Health and Me on MSNDemand For Weight Loss Injections Now ‘Unsustainable’, Experts Say Most Don’t QualifyExperts warn that the surge in demand for weight loss injections like Ozempic and Wegovy is unsustainable, with most users ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...
A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will need to show more robust growth in the months ahead to bolster market ...
The FDA has recently held a slew of so-called "expert panels" that sidestep legal procedures and ethics guardrails ...
Weight-loss jab Wegovy sees another prescription boost after ban on copycats - Novo CEO ousted in May, in place until ...
The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...
Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...
Dozens of lawmakers are urging U.S. health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results